Home » Grants/Awards » 1R01CA179120-01A1, NIH/NCI – MicroRNAs: Safe and Effective Therapeutic Adjuvants for Treating Triple-Negative Breast Cancers.

1R01CA179120-01A1, NIH/NCI – MicroRNAs: Safe and Effective Therapeutic Adjuvants for Treating Triple-Negative Breast Cancers.

2015/02/01-2021/01/31

MicroRNAs: Safe and effective therapeutic adjuvants for treating triple-negative breast cancers.

Manjeet Rao (PI)

Major Goals: To test the hypothesis that miRNAs are effective therapeutic adjuvants to treat drug-resistant triple-negative breast cancers.

Role: PI